This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wong, J. Articles by Lee, P. Search for Related Content PubMed PubMed Citation Articles by Wong, J. Articles by Lee, P. Pubmed/NCBI databases Medline Plus Health Information Diabetes Social Bookmarking                         What's this?

The State of Lipid Control in Patients with Diabetes in a Public Health Care Centre

Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia, wongjinshyan{at}health.gov.my

F. Tan, MRCP

Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia

PY Lee, MMed

Department of Medicine, Faculty of Medicine and Health Sciences, University Malaysia Sarawak, Sarawak, Malaysia

Achieving treatment targets has been difficult in treating diabetic patients. This cross-sectional study describes the lipid profiles of patients with diabetes mellitus at a public primary health care centre in Sarawak, Malaysia. The targets for lipid control were based on the International Diabetes Federation recommendation (2002). 1031 patients (98% Type 2 Diabetes) were studied. Fasting lipid profiles were available in 990 (96%) patients. The mean total cholesterol was 5.3 ± 1.0 mmol/L, Triglycerides 1.90 ± 1.26 mmol/L, HDL-C 1.28 ± 0.33 mmol/ L and LDL-C 3.2 ± 0.9 mmol/L. Overall, 22% of patients achieved the treatment target for LDL-C level <2.6mmol/L. 67% of patients had HDL-C > 1.1 mmol/L and 42% of patients had a target TG level below 1.5 mmol/L. Of the 40% of patients who received lipid-lowering drug, 17% achieved LDL-C target, 50% had LDL-C 2.6-4.4mmol/ L and 33% have LDL-C > 4.0 mmol/L. For the remaining 60% not receiving any lipid lowering therapy, 68% had LDL-C between 2.6-4.0 mmol/L and 7% had LDL-C level > 4 mmol/L. Dyslipidemia is still under-treated despite the availability of effective pharmacological agents and the greatly increased risk of cardiovascular diseases in diabetic patients. Asia Pac J Public Health 2007; 19(3): 16-21.

Key Words: Cholesterol • dyslipidemia • diabetes mellitus • primary health care.

Asia-Pacific Journal of Public Health, Vol. 19, No. 3, 16-21 (2007)
DOI: 10.1177/101053950701900304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?